Sutro Biopharma (STRO) Shareholder's Equity (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Sutro Biopharma | 248.39 Mn | 248.39 Mn | - | -132.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -132.45 Mn |
| Sep 30, 2025 | -87.27 Mn |
| Jun 30, 2025 | -32.11 Mn |
| Mar 31, 2025 | -25.81 Mn |
| Dec 31, 2024 | 44.60 Mn |
| Sep 30, 2024 | 111.22 Mn |
| Jun 30, 2024 | 152.18 Mn |
| Mar 31, 2024 | 98.02 Mn |
| Dec 31, 2023 | 149.65 Mn |
| Sep 30, 2023 | 112.43 Mn |
| Jun 30, 2023 | 154.72 Mn |
| Mar 31, 2023 | 185.41 Mn |
| Dec 31, 2022 | 217.05 Mn |
| Sep 30, 2022 | 229.73 Mn |
| Jun 30, 2022 | 209.06 Mn |
| Mar 31, 2022 | 220.37 Mn |
| Dec 31, 2021 | 252.56 Mn |
| Sep 30, 2021 | 283.58 Mn |
| Jun 30, 2021 | 307.50 Mn |
| Mar 31, 2021 | 307.34 Mn |
| Dec 31, 2020 | 332.05 Mn |
| Sep 30, 2020 | 244.12 Mn |
| Jun 30, 2020 | 206.76 Mn |
| Mar 31, 2020 | 82.09 Mn |
| Dec 31, 2019 | 97.79 Mn |
| Sep 30, 2019 | 109.91 Mn |
| Jun 30, 2019 | 119.56 Mn |
| Mar 31, 2019 | 130.72 Mn |
| Dec 31, 2018 | 131.54 Mn |
| Sep 30, 2018 | -141.43 Mn |
| Jun 30, 2018 | -132.02 Mn |
| Mar 31, 2018 | -120.75 Mn |
| Dec 31, 2017 | -109.00 Mn |
| Dec 31, 2016 | -90.90 Mn |